Abstract:Background and aims As a member of mitochondrial sirtuins, Sirt4 plays a vital role in cellular metabolism and intracellular signal transduction; however, its effect on atherosclerosis is unclear. This study aimed to explore the effect of Sirt4 on atherosclerosis and its underlying mechanism. Methods In vivo , Apoe −/− and Apoe −/− /Sirt4 −/− mice were fed a high-fat diet to induce atherosclerosis. In vitro , peritoneal macrophages from two mouse types were extracted and treated with oxidized low-density lipoprotein to establish a cell model, THP-1 cells were used to observe the effect of Sirt4 on the adhesion ability of monocytes. The growth and composition of aortic plaques in two mouse types were analyzed by H&E staining, Oil Red O staining, Dil oxidized low-density lipoprotein, immunohistochemistry, real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. Transcriptome analysis and Western blotting were performed to explore the specific mechanism. Results Sirt4 deficiency aggravated atherosclerosis in mice. In vivo , aortic plaque size, lipid content, and expression of related inflammatory factors in Apoe −/− /Sirt4 −/− mice were higher than those in the control group, whereas the contents of collagen I and smooth muscle actin-α were significantly lower. Sirt4-deficient macrophages exhibited stronger lipid phagocytosis in vitro , and the adhesion ability of monocytes increased when Sirt4 expression decreased. Transcriptome analysis showed that the expression of CXCL2 and CXCL3 in Sirt4-deficient peritoneal macrophages increased significantly, which may play a role by activating the NF-κB pathway. In further verification, the results in vitro and in vivo showed that the expression of VCAM-1 and pro-inflammatory factors such as IL-6, TNF-α and IL-1β increased, whereas the expression of anti-inflammatory factor IL-37 decreased in Sirt4-deficient peritoneal macrophages and tissues. After blocking the effect with NK-κB inhibitor BAY11-7082, the inflammatory reaction in sirt4 deficient macrophages was also significantly decreased. Conclusions This study demonstrated that Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway, suggesting that Sirt4 may exhibit a protective effect in atherosclerosis, which provides a new strategy for clinical prevention and treatment of atherosclerosis.

Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis

Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells

Deletion of Sirtuin 6 Accelerates Endothelial Dysfunction and Atherosclerosis in Apolipoprotein E-Deficient Mice

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

Deacetylation of Caveolin-1 by Sirt6 Induces Autophagy and Retards High Glucose-Stimulated LDL Transcytosis and Atherosclerosis Formation

SIRT1 inhibition promotes atherosclerosis through impaired autophagy.

Sirtuin 6 Deacetylates Apoptosis-Associated Speck-Like Protein (ASC) to Inhibit Endothelial Cell Pyroptosis in Atherosclerosis

Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway

SIRT6: A potential therapeutic target for diabetic cardiomyopathy

SIRT6 Controls Hepatic Lipogenesis by Suppressing LXR, ChREBP, and SREBP1.

Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis

Sirtuin 6: A Potential Therapeutic Target for Cardiovascular Diseases.

Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health

Abstract P3138: The Regulatory Role Of Sirtuin 6 In Coronary Microvascular Dysfunction

SIRT1 mediates the inflammatory response of macrophages and regulates the TIMP3/ADAM17 pathway in atherosclerosis

Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders

SIRT6 Inhibits Inflammatory Response Through Regulation of NRF2 in Vascular Endothelial Cells

SIRT1 promotes macrophage polarization to enhance efferocytosis by regulating TXNIP/NLRP3 inflammasome pathway

Sirt6 regulates autophagy in AGE-treated endothelial cells via KLF4

Hepatic-Specific Disruption of Sirt6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis

SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway